Securities code: Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) securities abbreviation: Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) Announcement No.: 2022042 Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093)
Announcement on holding 2021 online performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) (hereinafter referred to as “the company”) disclosed the 2021 annual report and the 2021 annual report summary on cninfo.com on April 25, 2022. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company’s business performance and development strategy, the company is scheduled to be on “value online” (www.ir-online. CN.) from 15:00 to 16:30 on Friday, May 13, 2022 Hold the 2021 online performance briefing, communicate and exchange with investors, and widely listen to the opinions and suggestions of investors.
At that time, the attendees of this briefing are: Mr. Hua Yimin, chairman and general manager of the company, Mr. Liu Li, independent director, Mr. Zou Xiaodong, sponsor representative, Mr. Xu Lizhong, deputy general manager and chief financial officer, and Ms. Liu Xue, deputy general manager and Secretary of the board of directors. The annual performance presentation will be held in the form of network interaction, and investors can visit the website（ https://eseb.cn./UwEI7haY92 ）Or use wechat to scan the following small program codes to participate in interactive communication.
In order to fully respect investors and improve the pertinence of exchanges, the company’s 2021 annual performance description meeting is hereby proposed
Open solicitation of questions from investors. Investors can visit the website before 15:00 on Wednesday, May 11, 2022（ https://eseb.cn./UwEI7haY92 ）Or scan the small program code above and click “enter the meeting” to ask questions before the meeting. The company will answer the questions generally concerned by investors within the scope of information disclosure at the 2021 annual performance briefing. Investors are welcome to actively participate.
It is hereby announced.
Jiangsu Hualan New Pharmaceutical Material Co.Ltd(301093) board of directors may 5, 2022
